Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients

The role of exosomes in CNS inflammation and their involvement in multiple sclerosis

(2017) Igor Selmaj et al.   JOURNAL OF NEUROIMMUNOLOGY

Multiple sclerosis: Serum-derived exosomes express myelin proteins

(2017) Grazyna Galazka et al.   Multiple Sclerosis Journal

Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination

(2017) Marwan Chami et al.   PLoS One

Acid sphingomyelinase mediates human CD4+ T-cell signaling: potential roles in T-cell responses and diseases

(2017) Aiping Bai et al.   Cell Death & Disease

Multiple sclerosis: Serum-derived exosomes express myelin proteins

(2017) Grazyna Galazka et al.   Multiple Sclerosis Journal

Secretory sphingomyelinase in health and disease

(2015) Johannes Kornhuber et al.   BIOLOGICAL CHEMISTRY

An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis

(2015) Damiana Pieragostino et al.   Molecular BioSystems

Sphingolipid Metabolism Correlates with Cerebrospinal Fluid Beta Amyloid Levels in Alzheimer’s Disease

(2015) Alfred N. Fonteh et al.   PLoS One

Microvesicles: What is the Role in Multiple Sclerosis?

(2015) Tiziana Carandini et al.   Frontiers in Neurology

Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics

(2014) Oscar G. Vidaurre et al.   BRAIN

What are exosomes and how can they be used in multiple sclerosis therapy?

(2014) Aya D Pusic et al.   Expert Review of Neurotherapeutics

CD39 and CD161 Modulate Th17 Responses in Crohn's Disease

(2014) Aiping Bai et al.   JOURNAL OF IMMUNOLOGY

Body fluid biomarkers in multiple sclerosis

(2013) Manuel Comabella et al.   LANCET NEUROLOGY

Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid

(2013) Christiane Mühle et al.   PLoS One

Myeloid microvesicles are a marker and therapeutic target for neuroinflammation

(2012) Claudia Verderio et al.   ANNALS OF NEUROLOGY

OMIP-011: Characterization of circulating endothelial cells (CECs) in peripheral blood

(2012) Raskit Lachmann et al.   CYTOMETRY PART A

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

(2012) T Kalina et al.   LEUKEMIA

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Microparticle formation after co-culture of human whole blood and umbilical artery in a novel in vitro model of flow

(2011) Emma Holtom et al.   CYTOMETRY PART A

Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis

(2011) Piero Del Boccio et al.   Journal of Proteomics

Spingolipids in Multiple Sclerosis

(2010) Silke Walter et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

New perspectives in the natural history of multiple sclerosis

(2010) H. Tremlett et al.   NEUROLOGY

Acid sphingomyelinase activity triggers microparticle release from glial cells

(2009) Fabio Bianco et al.   EMBO JOURNAL

Lipid Mediators in the Neural Cell Nucleus: Their Metabolism, Signaling, and Association with Neurological Disorders

(2009) Akhlaq A. Farooqui   NEUROSCIENTIST

A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis

(2008) David Wheeler et al.   BRAIN

Deregulation of sphingolipid metabolism in Alzheimer's disease

(2008) Xingxuan He et al.   NEUROBIOLOGY OF AGING

Aβ1–42 stimulated T cells express P-PKC-δ and P-PKC-ζ in Alzheimer disease

(2007) Sebastiano Miscia et al.   NEUROBIOLOGY OF AGING